DELEK US HOLDINGS INC (DK)       23.14  -0.35 (-1.49%)

23.14  -0.35 (-1.49%)

US24665A1034 - Common Stock - After market: 23.14 0 (0%)


Fundamental Rating

5

Taking everything into account, DK scores 5 out of 10 in our fundamental rating. DK was compared to 385 industry peers in the Oil, Gas & Consumable Fuels industry. DK has a medium financial health rating, its profitability is only medium as well. DK is valued quite cheap, while showing a decent growth score. This is a good combination!




Profitability

Profitability Rating

4

The Piotroski-F score of DK is 8.00. This is a very strong score and indicates great health and profitability for DK.
DK's Return On Equity of 27.25% is in line with the rest of the industry. The industry average Return On Equity is 28.11%.

DK has a Return On Assets of 3.14%. This is below the industry average of 12.98%. 83% of the industry peers outperform DK.
DK has a Profit Margin of 1.27%. This is below the industry average of 26.04%. 97% of the industry peers outperform DK.
VS Industry

ROA (3.14%) VS Industry: 17% outperformed.

0.06
1,708.00

ROE (27.25%) VS Industry: 48% outperformed.

0.30
19,161.80

Profit Margin (1.27%) VS Industry: 3% outperformed.

0.07
334.14

Valuation

Valuation Rating

7

The Price/Earnings Ratio is 3.94, which indicates a rather cheap valuation of DK.
DK's Price/Earning Ratio is a bit cheaper than the industry average which is at 5.76.
With a Forward Price/Earnings Ratio of 6.00, the valuation of DK can be described as cheap.
The low PEG Ratio, which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.

With a price book ratio of 1.64, DK is valued correctly.
When comparing the price book ratio of DK to the average industry price book ratio of 1.45, DK is valued in line with its industry peers.
Compared to an average industry Enterprise Value to EBITDA ratio of 3.70, DK is valued more expensive than its industry peers.
VS Industry

Price/Earnings (3.94) VS Industry: 70% outperformed.

4,750.00
0.01

Price/Book (1.64) VS Industry: 42% outperformed.

3,984.80
0.04

Enterprise Value/ EBITDA (5) VS Industry: 40% outperformed.

227.31
0.12

Growth

Growth Rating

5

DK shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 292.79%, which is quite impressive.
Measured over the past 5 years, DK shows a very strong growth in Earnings Per Share. The EPS has been growing by 44.92% on average per year.
The Revenue has grown by 90.13% in the past year. This is a very strong growth!
The Revenue has been growing by 22.74% on average over the past 5 years. This is a very strong growth!

The Earnings Per Share is expected to decrease by -16.53% on average over the next 5 years. This is quite bad
When comparing the EPS growth rate of the last years to the growth rate of the upcoming 5 years, we see that the growth is decreasing.
DK is expected to show a very negative growth in Revenue. In the coming 5 years, the Revenue will decrease by -20.88% yearly.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming 5 years, we see that the growth is decreasing.

PastFuture
5Y3Y1Y1Y2Y3Y5Y
EPS44.92% 20.27% 292.79% -34.39% -37.22% -47.63% -16.53%
Revenue22.74% 29.61% 90.13% -32.25% -19.08% -20.88% N/A

Health

Health Rating

5

The Altman-Z score of DK is much better than the industry average of 2.05.
The Piotroski-F score of DK is 8.00. This is a very strong score and indicates great health and profitability for DK.
DK has a Current Ratio of 1.20. This is a normal value and indicates that DK is financially healthy and should not expect problems in meeting its short term obligations.
DK has a Current Ratio comparable to the industry average, which is at 1.17.

DK has an Altman-Z score of 2.97. This is not the best score and indicates that DK is in the grey zone with still only limited risk for bankruptcy at the moment.
A Quick Ratio of 0.71 indicates that DK may have some problems paying its short term obligations.
Compared to an average industry Quick Ratio of 1.01, DK is worse placed to pay its short term obligations than its industry peers.
DK has one of the worst Debt to Equity ratios in its industry. 96% of its industry peers require less debt for financing their operations.
VS Industry

Debt/Equity (3.16) VS Industry: 4% outperformed.

78.08
0.00

Quick Ratio (0.71) VS Industry: 31% outperformed.

0.00
279.52

Current Ratio (1.2) VS Industry: 52% outperformed.

0.00
279.52

Altman-Z (2.97) VS Industry: 64% outperformed.

-283,883.16
804.85

Dividend

Dividend Rating

5

Compared to an average S&P500 Dividend Yield of 2.60, DK pays a bit more dividend than the S&P500 average.
DK pays out 16.65% of its income as dividend. This is a sustainable payout ratio.
DK has been paying a dividend for at least 10 years, so it has a reliable track record.

DK has a Yearly Dividend Yield of 3.19%.
DK's Dividend Yield is slightly below the industry average, which is at 5.67.
VS Industry

Dividend Yield (3.19%) VS Industry: 28% outperformed.

0.32
64.51

DELEK US HOLDINGS INC23.14

NYSE:DK (3/29/2023, 7:04:00 PM)-0.35 (-1.49%)

After market: 23.14 0 (0%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)02-28 2023-02-28/bmo
Earnings (Next)05-01 2023-05-01/bmo
Inst Owners96.56%
Inst Owner Change-2.46%
Ins Owners1.06%
Ins Owner Change14.81%
Market Cap1.55B
Analysts51.43
Price Target32.83 (41.88%)
Dividend
Industry RankSector Rank
Dividend Yield 3.19%
Dividend Growth(5Y)N/A
DP16.65%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-Date03-09 2023-03-09 (0.22)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-34.62%
Min EPS beat(2)-74.39%
Max EPS beat(2)5.16%
EPS beat(4)3
Avg EPS beat(4)136.05%
Min EPS beat(4)-74.39%
Max EPS beat(4)582.77%
Revenue beat(2)2
Avg Revenue beat(2)37.06%
Min Revenue beat(2)31.55%
Max Revenue beat(2)42.57%
Revenue beat(4)4
Avg Revenue beat(4)41.25%
Min Revenue beat(4)31.55%
Max Revenue beat(4)46.73%
PT rev (1m)1.14%
PT rev (3m)-8.05%
EPS NQ rev (1m)-9.56%
EPS NQ rev (3m)-19.13%
EPS NY rev (1m)-13.1%
EPS NY rev (3m)-13.1%
Revenue NQ rev (1m)-14.74%
Revenue NQ rev (3m)-24.89%
Revenue NY rev (1m)-8.2%
Revenue NY rev (3m)-8.2%
Valuation
Industry RankSector Rank
PE 3.94
Fwd PE 6
P/S 0.08
P/FCF 14.3
P/OCF 3.64
P/B 1.64
P/tB N/A
EV/EBITDA 5
EPS(TTM)5.88
EY25.41%
EPS(NY)3.86
Fwd EY16.67%
FCF(TTM)1.62
FCFY6.99%
OCF(TTM)6.35
OCFY27.46%
SpS302.44
BVpS14.1
TBVpS-1.74
PEG (NY)N/A
PEG (5Y)0.09
Profitability
Industry RankSector Rank
ROA 3.14%
ROE 27.25%
ROIC 7.54%
ROICexc 9.02%
ROICexgc 12.01%
OM 2.32%
PM 1.27%
GM 9.39%
ROICexgc(3y)N/A
ROICexcg growth 3Y-7.98%
ROICexcg growth 5Y-3.85%
ROICexc(3y)N/A
ROICexc growth 3Y-7.48%
ROICexc growth 5Y0.37%
OM growth 3Y-25.19%
OM growth 5Y-7.73%
PM growth 3Y-27.59%
PM growth 5Y-20.41%
GM growth 3Y-19.34%
GM growth 5Y-7.58%
F-Score8
Asset Turnover2.47
Health
Industry RankSector Rank
Debt/Equity 3.16
Debt/FCF 28.2
Debt/EBITDA 4.04
Cap/Depr 110.45%
Profit Quality 42.12%
Current Ratio 1.2
Quick Ratio 0.71
Altman-Z 2.97
F-Score8
WACC9.26%
ROIC/WACC1.3
Cap/Depr(3y)98.84%
Cap/Depr(5y)137.16%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
Growth
EPS 1Y292.79%
EPS 3Y20.27%
EPS 5Y44.92%
EPS growth Q2Q244.26%
EPS Next Y-34.39%
EPS Next 2Y-37.22%
EPS Next 3Y-47.63%
EPS Next 5Y-16.53%
Revenue growth 1Y90.13%
Revenue growth 3Y29.61%
Revenue growth 5Y22.74%
Revenue growth Q2Q44.12%
Revenue Next Year-32.25%
Revenue Next 2Y-19.08%
Revenue Next 3Y-20.88%
Revenue Next 5YN/A
EBIT growth 1Y676.07%
EBIT growth 3Y-3.04%
EBIT growth 5Y13.25%
EBIT Next Year21.3%
EBIT Next 3Y-4.34%
EBIT Next 5Y-8.03%
FCF growth 1Y-26.92%
FCF growth 3Y-6.92%
FCF growth 5Y-5.3%
OCF growth 1Y14.51%
OCF growth 3Y-9.57%
OCF growth 5Y5.87%

Fundamental Stock Screener Links

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA